Faircrete AE foam is a concentrated foaming agent used for producing controlled low strength cementitious materials like mortar and concrete. It offers numerous benefits including resistance to freeze/thaw cycles, excellent fire-resistance, good thermal insulation, and suitability for various applications such as infill and lightweight foundations. The product is supplied in various packaging sizes, with recommended dosage ranging from 0.6% to 1.5% by weight of the cementitious material, optimized through site trials.

1. FAIRCRETE AE FOAM
FOAMING AGENT ADMIXTURE FOR
CONCRETE & MORTAR

2. Benefits
 Loadings on foam sections not deflected into adjoining ground /
structures.
 will not break down when attacked by hydrocarbons, bacteria or fungi.
 Highly fluid material, suitable for pumping over long distances.
 Self-levelling, no vibration or compaction is required.
 Highly resistant to damage by freeze / thaw cycle.
 Good thermal insulation properties.
 Good energy absorbing properties.
 Excellent fire-resistance.
 Environmentally sound Foam Concrete Applications

3. Description
FAIRCRETE AE FOAM is a highly concentrated foaming agent for
use in producing controlled low strength materials cementitious
mixture (mortar, concrete, grout) for numerous application. It is
conforming to BS 5075 & ASTM C- 869 Type.

4. Uses
FAIRCRETE AE FOAM can be used for a wide range of applications
as infill and insulation as well as light weight foundations.

5. Physical Characteristics
Appearance : Brown colour Liquid
Chloride content : < 0.2 % as per as IS : 9103 : 1999
pH : 6 to 10

6. Packing & Dosage
FAIRCRETE AE FOAM is supplied in 1,5,10, 50, 100 & 200
Ltrs. carboys.
FAIRCRETE AE FOAM can be added at a dosage of 0.6 % to
1.5% by weight of cementItious material. However, the
optimum dosage should be determined by site trials.

7. Packing & Dosage
FAIRCRETE AE FOAM is supplied in 1,5,10, 50, 100 & 200
Ltrs. carboys.
FAIRCRETE AE FOAM can be added at a dosage of 0.6 % to
1.5% by weight of cementItious material. However, the
optimum dosage should be determined by site trials.